Erasca, Inc.
ERAS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001761918
No open-market purchases or sales by Erasca, Inc. insiders were filed in the last 90 days; 256 institutions reported holding it in 13F filings for Q2 2026, worth $5.13B in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Erasca, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 142 | 2 | 141 | +1 |
| Shares | 218.1M | 44.4K | 214.9M | −3.16M (−1.4%) |
| Value | $277.1M | $56.4K | $468.5M | +$191.5M (+69.1%) |
2 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Erasca, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 341,799 | $745.1K | 0.00% |
| Deutsche Bank AG | 165,895 | $361.7K | 0.00% |
| Squarepoint Ops LLC | 84,701 | $184.6K | 0.00% |
| American Century Companies Inc | 35,454 | $77.3K | 0.00% |
| Engineers Gate Manager LP | 34,523 | $75.3K | 0.00% |
| CIBC Bancorp USA Inc. | 18,504 | $40.3K | 0.00% |
| Crowley Wealth Management, Inc. | 15,000 | $32.7K | 0.03% |
| SG Americas Securities, LLC | 14,605 | $32.0K | 0.00% |
| Russell Investments Group, Ltd. | 14,378 | $31.3K | 0.00% |
| GTS Securities LLC | 10,775 | $23.5K | 0.00% |
| SRS Capital Advisors, Inc. | 7,681 | $16.7K | 0.00% |
| Optiver Holding B.V. | 1,424 | $3.10K | 0.00% |
| Clear Street Markets LLC | 1,072 | $2.34K | 0.00% |
| Sunbelt Securities, Inc. | 162 | $353 | 0.00% |
| Farther Finance Advisors, LLC | 100 | $218 | 0.00% |
| Clearstead Advisors, LLC | 2 | $5 | 0.00% |
| Cloud Capital Management, LLC | 21 | $0 | 0.00% |
Sold out (16)
Institutions that held Erasca, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| PFM Health Sciences, LP | 1,072,224 | $1.36M |
| Jain Global LLC | 774,340 | $983.4K |
| Octagon Capital Advisors LP | 700,000 | $889.0K |
| Atom Investors LP | 549,959 | $698.4K |
| Prosight Management, LP | 240,295 | $305.2K |
| HRT Financial LP | 156,160 | $198.0K |
| Franklin Resources Inc | 122,128 | $155.1K |
| XTX Topco Ltd | 106,779 | $135.6K |
| Dynamic Technology Lab Private Ltd | 29,177 | $37.0K |
| Catalyst Funds Management Pty Ltd | 13,061 | $16.6K |
| HSBC Holdings PLC | 11,090 | $14.3K |
| Mariner, LLC | 10,092 | $12.8K |
| Raymond James Financial Inc | 2,000 | $2.54K |
| MAI Capital Management | 467 | $594 |
| Skopos Labs, Inc. | 408 | $519 |
| Fortitude Family Office, LLC | 360 | $457 |
Not filed for Q3 2025 yet (2)
Institutions that held Erasca, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| EP Wealth Advisors, LLC | 23,000 | $29.2K |
| CIBC World Markets Corp | 21,388 | $27.2K |